Shop

Showing 1873–1888 of 1900 results

• 

  Article: Vaccine response in patients receiving anti-B-cell targeted therapy

  €2.42 Add to cart
• 

  Article: Validation of a ready to use Clauss fibrinogen

  €2.42 Add to cart
• 

  Article: Value and implications of the anti-Xa activity monitoring in pregnant women receiving prophylactic LMWH: a retrospective study

  €2.42 Add to cart
• 

  Article: Vascular safety profile of new generation BCR-ABL tyrosine kinase inhibitors in the treatment of chronic myeloid leukaemia

  €2.42 Add to cart
• 

  Article: Venetoclax-rituximab induces deep responses in relapsed CLL

  €2.42 Add to cart
• 

  Article: Venetoclax, the first available bcl-2 antagonist for chronic lymphocytic leukaemia

  €2.42 Add to cart
• 

  Article: Venetoclax, the first available bcl-2 antagonist for chronic lymphocytic leukaemia

  €2.42 Add to cart
• 

  Article: VENOUS THROMBOEMBOLISM

  €2.42 Add to cart
• 

  Article: Volume 6, Issue 1, February 2012

  €2.42 Add to cart
• 

  Article: Von Willebrand factor and ADAMTS13: new players in ischemia/reperfusion injury

  €2.42 Add to cart
• 

  Article: VON WILLEBRAND FACTOR: A NEW FLOW MARKER IN CARDIOVASCULAR PATHOLOGY

  €2.42 Add to cart
• 

  Article: Waldenstrom’s macroglobulinaemia: Belgian Hematology Society guidelines

  €2.42 Add to cart
• 

  Article: What about oligometastatic therapy in prostate cancer?

  €2.42 Add to cart
• 

  Article: What about oligometastatic therapy in prostate cancer?

  €2.42 Add to cart
• 

  Article: What About Oligometastatic Therapy In Prostate Cancer? Special,

  €2.42 Add to cart
• 

  Article: What can the tumour microenvironment tell us?

  €2.42 Add to cart